968a: ETRASIMOD 2MG ONCE DAILY AS TREATMENT FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Autor:	William J. Sandborn, Severine Vermeire, Laurent Peyrin-Biroulet, Marla C. Dubinsky, Julian Panes, Andres J. Yarur, Timothy E. Ritter, Filip J. Baert, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael V. Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D'Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan
Rok vydání:	2022
Předmět:	Hepatology Gastroenterology
Zdroj:	Gastroenterology. 162:S-1395
ISSN:	0016-5085
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c767d54825d84d5eb5130258f523cbcf https://doi.org/10.1016/s0016-5085(22)64063-0 Zobrazit plný text záznamu